Apotex Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Apotex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013558
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Richmond Hill, Toronto, Etobicoke, Brantford, Windsor and Winnipeg. It has manufacturing and distribution facilities across the world and offers its products to patients, healthcare providers and payers, governments and other pharmaceutical manufacturers the world over. It operates through subsidiaries, joint ventures and licensing agreements in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.

Apotex Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Apotex Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Charterhouse Capital Partners Acquires Doc Generici For US$424 Million 10
Licensing Agreements 12
Panacea Biotec Expands Licensing Agreement with Apotex 12
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 13
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 15
Acquisition 16
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 16
Apotex Inc – Key Competitors 17
Apotex Inc – Key Employees 18
Apotex Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Legal and Regulatory 21
Oct 03, 2016: Apotex Files Lawsuit Seeking Compensation for “Improper” Government Actions 21
Other Significant Developments 22
Mar 08, 2017: Apotex Announces $184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company’s Largest Investment in the United States 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Apotex Inc, Pharmaceuticals & Healthcare, Key Facts 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Apotex Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Charterhouse Capital Partners Acquires Doc Generici For US$424 Million 10
Panacea Biotec Expands Licensing Agreement with Apotex 12
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 13
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 15
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 16
Apotex Inc, Key Competitors 17
Apotex Inc, Key Employees 18
Apotex Inc, Subsidiaries 19

★海外企業調査レポート[Apotex Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hyundai Motor Co (005380):企業の財務・戦略的SWOT分析
    Hyundai Motor Co (005380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Schroders Plc:企業の戦略・SWOT・財務情報
    Schroders Plc - Strategy, SWOT and Corporate Finance Report Summary Schroders Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Amathus Public Ltd:企業の戦略・SWOT・財務情報
    Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • numares AG:企業の製品パイプライン分析2018
    Summary Numares AG (Numares), formerly Numares GmbH, is a developer and marketer of products for life science research and clinical diagnostics. The company’s AXINON lipoFIT, a test system used for lipoprotein profiling, while insightLP provides insights into lipid related research using lipoprotein …
  • Filtronic plc:企業の戦略・SWOT・財務分析
    Filtronic plc - Strategy, SWOT and Corporate Finance Report Summary Filtronic plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Pharos Energy Plc (PHAR):企業の財務・戦略的SWOT分析
    Summary Pharos Energy Plc (Pharos) is an oil and gas company that explores, discovers and produces oil and gas reserves. The company offers appraisal and field development services. It provides training and skills and support local communities. Pharos produces and supplies natural resources. Pharos …
  • Escalier Biosciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Escalier Biosciences BV (Escalier Biosciences) is a biopharmaceutical company, which develops small molecule medicines for the treatment of autoimmune disorders. Its pipeline products include topical and oral RAR-related orphan receptor gamma inverse agonists. Inhibition of RAR-related orpha …
  • Tokyo Electric Power Company Holdings Incorporated (9501):電力:M&Aディール及び事業提携情報
    Summary Tokyo Electric Power Company Holdings Incorporated (TEPCO) is an energy utility. It generates, transmits and distributes electricity; transports fuel; and retails electricity and gas. The company produces power using coal, gas, LNG, solar, wind and hydro sources. TEPCO has presence in the en …
  • Vergnet SA (ALVER)-エネルギー分野:企業M&A・提携分析
    Summary Vergnet SA (Vergnet) is a renewable energy company. It designs, develops, and manufactures renewable solutions. The company offers wind, solar and hybrid energy solutions besides solar applications. Through its technology Hybrid Wizard, Vergnet offers real-time hybrid controller solutions fo …
  • Spectrum Pharmaceuticals Inc (SPPI)-製薬・医療分野:企業M&A・提携分析
    Summary Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company’s marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection) …
  • KARL STORZ GmbH & Co KG-医療機器分野:企業M&A・提携分析
    Summary KARL STORZ GmbH & Co KG (Karl Storz) is a manufacturer and distributor of endoscopes, surgical devices and medical instruments. The company offers rigid and flexible endoscopes, instruments for the field of human medicine used for neurosurgery; oral and maxillofacial surgery; ear, nose, and …
  • Muscatine Power and Water:企業の戦略的SWOT分析
    Muscatine Power and Water - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ornim Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ornim Inc (Ornim) is a medical device company that specializes in clinical research, development and distribution of medical devices in the field of tissue and cerebral blood flow and perfusion, among others. The company’s c-FLOW is a continuous non-invasive monitor of deep tissue blood flow …
  • Allergan Plc (AGN):企業の財務・戦略的SWOT分析
    Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Atox Bio Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atox Bio Ltd (Atox Bio) is a late state biotechnology company that develops immunomodulators to treat critically ill patients with severe infections. The company develops drugs for patients suffering from necrotizing soft tissue infections, a flesh eating bacteria. It implements novel mode o …
  • Eqtec plc (EQT):電力:M&Aディール及び事業提携情報
    Summary Eqtec plc (Eqtec), formerly React Energy Plc, is a renewable energy company that develops, identifies, builds and operates renewable energy electricity and heat generation plants. The company carries out gasification technology used in industrial size power plants to convert waste into synth …
  • Skipton Building Society (SBSB):企業の財務・戦略的SWOT分析
    Skipton Building Society (SBSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Consolidated Edison Inc (ED):石油・ガス:M&Aディール及び事業提携情報
    Summary Consolidated Edison, Inc. (Con Edison) is an investor-owned energy company that offers wide range energy related products and services through its subsidiaries. It operates regulated electricity, gas and steam businesses, and competitive energy businesses. Con Edison’s competitive energy bus …
  • Elcam Medical:企業の製品パイプライン分析2018
    Summary Elcam Medical (Elcam) is a medical device company that produces disposable medical devices and components for the OEM market, and provides novel solutions for specialized flow control needs. The company offers products, which are used in the areas of intensive care medicine, anesthesia, infe …
  • The Singing Machine Company, Inc.:戦略・SWOT・企業財務分析
    The Singing Machine Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Singing Machine Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆